What is Ibex Technologies Return-on-Tangible-Equity?
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Ibex Technologies's annualized net income for the quarter that ended in Jan. 2024 was C$0.20 Mil. Ibex Technologies's average shareholder tangible equity for the quarter that ended in Jan. 2024 was C$14.27 Mil. Therefore, Ibex Technologies's annualized Return-on-Tangible-Equity for the quarter that ended in Jan. 2024 was 1.40%.
The historical rank and industry rank for Ibex Technologies's Return-on-Tangible-Equity or its related term are showing as below:
TSXV:IBT'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -17.72 Med: 7.45 Max: 47.72
Current: 31.04
During the past 13 years, Ibex Technologies's highest Return-on-Tangible-Equity was 47.72%. The lowest was -17.72%. And the median was 7.45%.
TSXV:IBT's Return-on-Tangible-Equity is ranked better than 94.93% of 1303
companies
in the Biotechnology industry
Industry Median: -46.56
vs TSXV:IBT: 31.04
Ibex Technologies Return-on-Tangible-Equity Historical Data
The historical data trend for Ibex Technologies's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ibex Technologies's Return-on-Tangible-Equity
For the Biotechnology subindustry, Ibex Technologies's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ibex Technologies's Return-on-Tangible-Equity Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ibex Technologies's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Ibex Technologies's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jan. 2024) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Ibex Technologies Return-on-Tangible-Equity Related Terms
Thank you for viewing the detailed overview of Ibex Technologies's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSXV:IBT has been successfully added to your 